Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
31.80
+7.90 (33.05%)
At close: Oct 27, 2025, 4:00 PM EDT
31.50
-0.30 (-0.94%)
After-hours: Oct 27, 2025, 7:58 PM EDT
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.34 billion as of October 27, 2025. Its market cap has increased by 96.80% in one year.
Market Cap
1.34B
Enterprise Value
1.07B
1-Year Change
96.80%
Ranking
Category
Stock Price
$31.80
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.34B, an increase of 97.96%. That is a compound annual growth rate of 84.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 1.01B | 193.99% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.93B |
| Johnson & Johnson | 457.86B |
| AbbVie | 402.10B |
| UnitedHealth Group | 329.53B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.42B |